Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present SteadyMed Ltd. (NASDAQ: STDY).

Full DD Report for STDY

You must become a subscriber to view this report.


Recent News from (NASDAQ: STDY)

Merger Arbitrage Mondays - September 24, 2018
Merger activity increased last week with nine new deals announced and two pending deals closing. For folks who were long SteadyMed (STDY), brokers have started sending out letters with the form you can fill out to make sure 25% of the amount due is not withheld for taxes according to Israeli l...
Source: SeekingAlpha
Date: September, 25 2018 10:39
Daily Insider Ratings Round Up 9/4/18
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
Source: SeekingAlpha
Date: September, 06 2018 01:30
Merger Arbitrage Mondays - September 3, 2018
Merger activity remained unchanged last week with three new deals announced and three pending deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. There were two new deals announced in the Deals i...
Source: SeekingAlpha
Date: September, 04 2018 04:10
United Therapeutics Corporation Completes Acquisition Of SteadyMed Ltd.
SILVER SPRING, Md. , Aug. 30, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) ("United Therapeutics") today announced that it has closed the merger of SteadyMed Ltd. (NASDAQ: STDY) ("SteadyMed") with a subsidiary of United Therapeutics. Pursuant to the merger, Uni...
Source: PR Newswire
Date: August, 30 2018 07:08
SteadyMed Provides Corporate Update and Reports Second Quarter 2018 Financial Results
SAN RAMON, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq: STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral delivery needs, today provided a corporate update and an...
Source: GlobeNewswire
Date: August, 14 2018 06:00
Merger Arbitrage Mondays: August 13, 2018
Merger activity decreased last week with three new deals announced and one pending deal closing. We also had two deals that failed as discussed in the deal updates section below. After several years of low deal failures (more than 95% of all deals closed), 2018 has turned out to be a difficult...
Source: SeekingAlpha
Date: August, 13 2018 07:53
SteadyMed shareholders approve proposed acquisition by United Therapeutics
SteadyMed ( STDY ) announced that their shareholders voted to approve the previously announced acquisition of the company by United Therapeutics ( UTHR -2.2% ). More news on: SteadyMed, United Therapeutics Corporation, Read more ...
Source: SeekingAlpha
Date: July, 31 2018 06:27
SteadyMed Shareholders Approve Proposed Acquisition by United Therapeutics
SAN RAMON, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq: STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral delivery needs, today announced that SteadyMed sharehold...
Source: GlobeNewswire
Date: July, 31 2018 06:00
HSR Act Waiting Period Terminated for United Therapeutics' Acquisition of SteadyMed Ltd.
SILVER SPRING, Md. and SAN RAMON, Calif., July 20, 2018 (GLOBE NEWSWIRE) -- United Therapeutics Corporation (NASDAQ:UTHR) and SteadyMed Ltd. (NASDAQ:STDY) announced today the termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Ac...
Source: GlobeNewswire
Date: July, 20 2018 06:00
Merger Arbitrage Mondays - July 9, 2018
Merger activity decreased last week with three new deals announced and seven pending deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool (MAT) that automatically updates itself during market hours. There were no new deals announced in the Deals in th...
Source: SeekingAlpha
Date: July, 09 2018 12:53

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-03N/A4.725N/AN/A0
2018-08-31N/A4.725N/AN/A0
2018-08-30N/A4.725N/AN/A160
2018-08-294.754.7254.804.675647,540
2018-08-284.704.704.754.67566,640

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-2954,464405,99713.4149Cover
2018-08-2829,40032,60090.1840Short
2018-08-2713,40027,23849.1960Short
2018-08-2418,62928,87464.5183Short
2018-08-2313,40222,24360.2527Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on STDY.


About SteadyMed Ltd. (NASDAQ: STDY)

Logo for SteadyMed Ltd. (NASDAQ: STDY)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $124,891,779 - 05/11/2018
  • Issue and Outstanding: 26,572,719 - 03/15/2018

 


Recent Filings from (NASDAQ: STDY)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: May, 11 2018
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Type: SC 13DFiling Source: edgar
Filing Date: May, 07 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: May, 01 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 30 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 30 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 30 2018

 

 


Daily Technical Chart for (NASDAQ: STDY)

Daily Technical Chart for (NASDAQ: STDY)


Stay tuned for daily updates and more on (NASDAQ: STDY)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: STDY)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in STDY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of STDY and does not buy, sell, or trade any shares of STDY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/